認知機能低下のグローバル市場展望 2023年-2029年:リンエステラーゼ阻害剤、NMDA受容体拮抗薬

■ 英語タイトル:Cognitive Decline Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート(データ管理コード:MMG23LY8428)■ 発行会社/調査会社:Market Monitor Global
■ 商品コード:MMG23LY8428
■ 発行日:2023年7月
■ 調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野:医薬品&ヘルスケア
■ ページ数:117
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥487,500見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥633,750見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥731,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[認知機能低下のグローバル市場展望 2023年-2029年:リンエステラーゼ阻害剤、NMDA受容体拮抗薬]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査レポートは次の情報を含め、世界の認知機能低下市場規模と予測を収録しています。・世界の認知機能低下市場:売上、2018年-2023年、2024年-2029年
・世界の認知機能低下市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の認知機能低下市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リンエステラーゼ阻害剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

認知機能低下のグローバル主要企業は、Stryker、 Smith & Nephew、 Hill-Rom Services Inc.、 Paramount Bed Holdings Co., Ltd.、 ArjoHuntleigh、 Talley Group Limited、 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)、 Apex Medical Corp.、 Medtronic、 PROMA REHA, s. r. o.、 Linet spol. S R.O.、 DARCO International、 DeRoyal Industries、 BSN Medical (Essity)、 Mölnlycke Health Care、 TrueKAST (Wound Kair Concepts)、 Thuasne SAS、 DJO Global、 ORTHOSERVICE AG、 Breg, Inc.、 Advanced Orthopaedics、 ALGEOS、 Hollister Incorporated、 ConvaTec Group plc、 Coloplast A/S、 Medline Industries Inc.、 Invacare Corporationなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、認知機能低下のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の認知機能低下市場:タイプ別、2018年-2023年、2024年-2029年
世界の認知機能低下市場:タイプ別市場シェア、2022年
・リンエステラーゼ阻害剤、NMDA受容体拮抗薬

世界の認知機能低下市場:用途別、2018年-2023年、2024年-2029年
世界の認知機能低下市場:用途別市場シェア、2022年
・軽度認知障害(MCI)、認知症

世界の認知機能低下市場:地域・国別、2018年-2023年、2024年-2029年
世界の認知機能低下市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における認知機能低下のグローバル売上、2018年-2023年
・主要企業における認知機能低下のグローバル売上シェア、2022年
・主要企業における認知機能低下のグローバル販売量、2018年-2023年
・主要企業における認知機能低下のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Stryker、 Smith & Nephew、 Hill-Rom Services Inc.、 Paramount Bed Holdings Co., Ltd.、 ArjoHuntleigh、 Talley Group Limited、 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)、 Apex Medical Corp.、 Medtronic、 PROMA REHA, s. r. o.、 Linet spol. S R.O.、 DARCO International、 DeRoyal Industries、 BSN Medical (Essity)、 Mölnlycke Health Care、 TrueKAST (Wound Kair Concepts)、 Thuasne SAS、 DJO Global、 ORTHOSERVICE AG、 Breg, Inc.、 Advanced Orthopaedics、 ALGEOS、 Hollister Incorporated、 ConvaTec Group plc、 Coloplast A/S、 Medline Industries Inc.、 Invacare Corporation

*************************************************************

・調査・分析レポートの概要
認知機能低下市場の定義
市場セグメント
世界の認知機能低下市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の認知機能低下市場規模
世界の認知機能低下市場規模:2022年 VS 2029年
世界の認知機能低下市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの認知機能低下の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の認知機能低下製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:リンエステラーゼ阻害剤、NMDA受容体拮抗薬
認知機能低下のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:軽度認知障害(MCI)、認知症
認知機能低下の用途別グローバル売上・予測

・地域別市場分析
地域別認知機能低下市場規模 2022年と2029年
地域別認知機能低下売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Stryker、 Smith & Nephew、 Hill-Rom Services Inc.、 Paramount Bed Holdings Co., Ltd.、 ArjoHuntleigh、 Talley Group Limited、 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)、 Apex Medical Corp.、 Medtronic、 PROMA REHA, s. r. o.、 Linet spol. S R.O.、 DARCO International、 DeRoyal Industries、 BSN Medical (Essity)、 Mölnlycke Health Care、 TrueKAST (Wound Kair Concepts)、 Thuasne SAS、 DJO Global、 ORTHOSERVICE AG、 Breg, Inc.、 Advanced Orthopaedics、 ALGEOS、 Hollister Incorporated、 ConvaTec Group plc、 Coloplast A/S、 Medline Industries Inc.、 Invacare Corporation
...

This report aims to provide a comprehensive presentation of the global market for Cognitive Decline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cognitive Decline. This report contains market size and forecasts of Cognitive Decline in global, including the following market information:
Global Cognitive Decline Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cognitive Decline market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
by Drug Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cognitive Decline include Stryker, Smith & Nephew, Hill-Rom Services Inc., Paramount Bed Holdings Co., Ltd., ArjoHuntleigh, Talley Group Limited, Drive DeVilbiss Healthcare Ltd (Sidhil Limited), Apex Medical Corp. and Medtronic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cognitive Decline companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cognitive Decline Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cognitive Decline Market Segment Percentages, by Type, 2022 (%)
by Drug Therapy
Cholinesterase Inhibitors
NMDA receptor antagonists
by Non-Invasive Stimulation Devices
Vagus Nerve Stimulators
Deep Brain Stimulators
Transcranial Magnetic Stimulators (TMSs)
Global Cognitive Decline Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cognitive Decline Market Segment Percentages, by Application, 2022 (%)
Mild Cognitive Impairment (MCI)
Dementia
Global Cognitive Decline Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cognitive Decline Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cognitive Decline revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cognitive Decline revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Stryker
Smith & Nephew
Hill-Rom Services Inc.
Paramount Bed Holdings Co., Ltd.
ArjoHuntleigh
Talley Group Limited
Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
Apex Medical Corp.
Medtronic
PROMA REHA, s. r. o.
Linet spol. S R.O.
DARCO International
DeRoyal Industries
BSN Medical (Essity)
Mölnlycke Health Care
TrueKAST (Wound Kair Concepts)
Thuasne SAS
DJO Global
ORTHOSERVICE AG
Breg, Inc.
Advanced Orthopaedics
ALGEOS
Hollister Incorporated
ConvaTec Group plc
Coloplast A/S
Medline Industries Inc.
Invacare Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cognitive Decline, market overview.
Chapter 2: Global Cognitive Decline market size in revenue.
Chapter 3: Detailed analysis of Cognitive Decline company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cognitive Decline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Introduction to Research & Analysis Reports
1.1 Cognitive Decline Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cognitive Decline Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cognitive Decline Overall Market Size
2.1 Global Cognitive Decline Market Size: 2022 VS 2029
2.2 Global Cognitive Decline Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cognitive Decline Players in Global Market
3.2 Top Global Cognitive Decline Companies Ranked by Revenue
3.3 Global Cognitive Decline Revenue by Companies
3.4 Top 3 and Top 5 Cognitive Decline Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cognitive Decline Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cognitive Decline Players in Global Market
3.6.1 List of Global Tier 1 Cognitive Decline Companies
3.6.2 List of Global Tier 2 and Tier 3 Cognitive Decline Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cognitive Decline Market Size Markets, 2022 & 2029
4.1.2 Cholinesterase Inhibitors
4.1.3 NMDA receptor antagonists
4.2 By Type – Global Cognitive Decline Revenue & Forecasts
4.2.1 By Type – Global Cognitive Decline Revenue, 2018-2023
4.2.2 By Type – Global Cognitive Decline Revenue, 2024-2029
4.2.3 By Type – Global Cognitive Decline Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cognitive Decline Market Size, 2022 & 2029
5.1.2 Mild Cognitive Impairment (MCI)
5.1.3 Dementia
5.2 By Application – Global Cognitive Decline Revenue & Forecasts
5.2.1 By Application – Global Cognitive Decline Revenue, 2018-2023
5.2.2 By Application – Global Cognitive Decline Revenue, 2024-2029
5.2.3 By Application – Global Cognitive Decline Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cognitive Decline Market Size, 2022 & 2029
6.2 By Region – Global Cognitive Decline Revenue & Forecasts
6.2.1 By Region – Global Cognitive Decline Revenue, 2018-2023
6.2.2 By Region – Global Cognitive Decline Revenue, 2024-2029
6.2.3 By Region – Global Cognitive Decline Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cognitive Decline Revenue, 2018-2029
6.3.2 US Cognitive Decline Market Size, 2018-2029
6.3.3 Canada Cognitive Decline Market Size, 2018-2029
6.3.4 Mexico Cognitive Decline Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cognitive Decline Revenue, 2018-2029
6.4.2 Germany Cognitive Decline Market Size, 2018-2029
6.4.3 France Cognitive Decline Market Size, 2018-2029
6.4.4 U.K. Cognitive Decline Market Size, 2018-2029
6.4.5 Italy Cognitive Decline Market Size, 2018-2029
6.4.6 Russia Cognitive Decline Market Size, 2018-2029
6.4.7 Nordic Countries Cognitive Decline Market Size, 2018-2029
6.4.8 Benelux Cognitive Decline Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cognitive Decline Revenue, 2018-2029
6.5.2 China Cognitive Decline Market Size, 2018-2029
6.5.3 Japan Cognitive Decline Market Size, 2018-2029
6.5.4 South Korea Cognitive Decline Market Size, 2018-2029
6.5.5 Southeast Asia Cognitive Decline Market Size, 2018-2029
6.5.6 India Cognitive Decline Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cognitive Decline Revenue, 2018-2029
6.6.2 Brazil Cognitive Decline Market Size, 2018-2029
6.6.3 Argentina Cognitive Decline Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cognitive Decline Revenue, 2018-2029
6.7.2 Turkey Cognitive Decline Market Size, 2018-2029
6.7.3 Israel Cognitive Decline Market Size, 2018-2029
6.7.4 Saudi Arabia Cognitive Decline Market Size, 2018-2029
6.7.5 UAE Cognitive Decline Market Size, 2018-2029
7 Cognitive Decline Companies Profiles
7.1 Stryker
7.1.1 Stryker Company Summary
7.1.2 Stryker Business Overview
7.1.3 Stryker Cognitive Decline Major Product Offerings
7.1.4 Stryker Cognitive Decline Revenue in Global Market (2018-2023)
7.1.5 Stryker Key News & Latest Developments
7.2 Smith & Nephew
7.2.1 Smith & Nephew Company Summary
7.2.2 Smith & Nephew Business Overview
7.2.3 Smith & Nephew Cognitive Decline Major Product Offerings
7.2.4 Smith & Nephew Cognitive Decline Revenue in Global Market (2018-2023)
7.2.5 Smith & Nephew Key News & Latest Developments
7.3 Hill-Rom Services Inc.
7.3.1 Hill-Rom Services Inc. Company Summary
7.3.2 Hill-Rom Services Inc. Business Overview
7.3.3 Hill-Rom Services Inc. Cognitive Decline Major Product Offerings
7.3.4 Hill-Rom Services Inc. Cognitive Decline Revenue in Global Market (2018-2023)
7.3.5 Hill-Rom Services Inc. Key News & Latest Developments
7.4 Paramount Bed Holdings Co., Ltd.
7.4.1 Paramount Bed Holdings Co., Ltd. Company Summary
7.4.2 Paramount Bed Holdings Co., Ltd. Business Overview
7.4.3 Paramount Bed Holdings Co., Ltd. Cognitive Decline Major Product Offerings
7.4.4 Paramount Bed Holdings Co., Ltd. Cognitive Decline Revenue in Global Market (2018-2023)
7.4.5 Paramount Bed Holdings Co., Ltd. Key News & Latest Developments
7.5 ArjoHuntleigh
7.5.1 ArjoHuntleigh Company Summary
7.5.2 ArjoHuntleigh Business Overview
7.5.3 ArjoHuntleigh Cognitive Decline Major Product Offerings
7.5.4 ArjoHuntleigh Cognitive Decline Revenue in Global Market (2018-2023)
7.5.5 ArjoHuntleigh Key News & Latest Developments
7.6 Talley Group Limited
7.6.1 Talley Group Limited Company Summary
7.6.2 Talley Group Limited Business Overview
7.6.3 Talley Group Limited Cognitive Decline Major Product Offerings
7.6.4 Talley Group Limited Cognitive Decline Revenue in Global Market (2018-2023)
7.6.5 Talley Group Limited Key News & Latest Developments
7.7 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
7.7.1 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Summary
7.7.2 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview
7.7.3 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Major Product Offerings
7.7.4 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Revenue in Global Market (2018-2023)
7.7.5 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Key News & Latest Developments
7.8 Apex Medical Corp.
7.8.1 Apex Medical Corp. Company Summary
7.8.2 Apex Medical Corp. Business Overview
7.8.3 Apex Medical Corp. Cognitive Decline Major Product Offerings
7.8.4 Apex Medical Corp. Cognitive Decline Revenue in Global Market (2018-2023)
7.8.5 Apex Medical Corp. Key News & Latest Developments
7.9 Medtronic
7.9.1 Medtronic Company Summary
7.9.2 Medtronic Business Overview
7.9.3 Medtronic Cognitive Decline Major Product Offerings
7.9.4 Medtronic Cognitive Decline Revenue in Global Market (2018-2023)
7.9.5 Medtronic Key News & Latest Developments
7.10 PROMA REHA, s. r. o.
7.10.1 PROMA REHA, s. r. o. Company Summary
7.10.2 PROMA REHA, s. r. o. Business Overview
7.10.3 PROMA REHA, s. r. o. Cognitive Decline Major Product Offerings
7.10.4 PROMA REHA, s. r. o. Cognitive Decline Revenue in Global Market (2018-2023)
7.10.5 PROMA REHA, s. r. o. Key News & Latest Developments
7.11 Linet spol. S R.O.
7.11.1 Linet spol. S R.O. Company Summary
7.11.2 Linet spol. S R.O. Business Overview
7.11.3 Linet spol. S R.O. Cognitive Decline Major Product Offerings
7.11.4 Linet spol. S R.O. Cognitive Decline Revenue in Global Market (2018-2023)
7.11.5 Linet spol. S R.O. Key News & Latest Developments
7.12 DARCO International
7.12.1 DARCO International Company Summary
7.12.2 DARCO International Business Overview
7.12.3 DARCO International Cognitive Decline Major Product Offerings
7.12.4 DARCO International Cognitive Decline Revenue in Global Market (2018-2023)
7.12.5 DARCO International Key News & Latest Developments
7.13 DeRoyal Industries
7.13.1 DeRoyal Industries Company Summary
7.13.2 DeRoyal Industries Business Overview
7.13.3 DeRoyal Industries Cognitive Decline Major Product Offerings
7.13.4 DeRoyal Industries Cognitive Decline Revenue in Global Market (2018-2023)
7.13.5 DeRoyal Industries Key News & Latest Developments
7.14 BSN Medical (Essity)
7.14.1 BSN Medical (Essity) Company Summary
7.14.2 BSN Medical (Essity) Business Overview
7.14.3 BSN Medical (Essity) Cognitive Decline Major Product Offerings
7.14.4 BSN Medical (Essity) Cognitive Decline Revenue in Global Market (2018-2023)
7.14.5 BSN Medical (Essity) Key News & Latest Developments
7.15 Mölnlycke Health Care
7.15.1 Mölnlycke Health Care Company Summary
7.15.2 Mölnlycke Health Care Business Overview
7.15.3 Mölnlycke Health Care Cognitive Decline Major Product Offerings
7.15.4 Mölnlycke Health Care Cognitive Decline Revenue in Global Market (2018-2023)
7.15.5 Mölnlycke Health Care Key News & Latest Developments
7.16 TrueKAST (Wound Kair Concepts)
7.16.1 TrueKAST (Wound Kair Concepts) Company Summary
7.16.2 TrueKAST (Wound Kair Concepts) Business Overview
7.16.3 TrueKAST (Wound Kair Concepts) Cognitive Decline Major Product Offerings
7.16.4 TrueKAST (Wound Kair Concepts) Cognitive Decline Revenue in Global Market (2018-2023)
7.16.5 TrueKAST (Wound Kair Concepts) Key News & Latest Developments
7.17 Thuasne SAS
7.17.1 Thuasne SAS Company Summary
7.17.2 Thuasne SAS Business Overview
7.17.3 Thuasne SAS Cognitive Decline Major Product Offerings
7.17.4 Thuasne SAS Cognitive Decline Revenue in Global Market (2018-2023)
7.17.5 Thuasne SAS Key News & Latest Developments
7.18 DJO Global
7.18.1 DJO Global Company Summary
7.18.2 DJO Global Business Overview
7.18.3 DJO Global Cognitive Decline Major Product Offerings
7.18.4 DJO Global Cognitive Decline Revenue in Global Market (2018-2023)
7.18.5 DJO Global Key News & Latest Developments
7.19 ORTHOSERVICE AG
7.19.1 ORTHOSERVICE AG Company Summary
7.19.2 ORTHOSERVICE AG Business Overview
7.19.3 ORTHOSERVICE AG Cognitive Decline Major Product Offerings
7.19.4 ORTHOSERVICE AG Cognitive Decline Revenue in Global Market (2018-2023)
7.19.5 ORTHOSERVICE AG Key News & Latest Developments
7.20 Breg, Inc.
7.20.1 Breg, Inc. Company Summary
7.20.2 Breg, Inc. Business Overview
7.20.3 Breg, Inc. Cognitive Decline Major Product Offerings
7.20.4 Breg, Inc. Cognitive Decline Revenue in Global Market (2018-2023)
7.20.5 Breg, Inc. Key News & Latest Developments
7.21 Advanced Orthopaedics
7.21.1 Advanced Orthopaedics Company Summary
7.21.2 Advanced Orthopaedics Business Overview
7.21.3 Advanced Orthopaedics Cognitive Decline Major Product Offerings
7.21.4 Advanced Orthopaedics Cognitive Decline Revenue in Global Market (2018-2023)
7.21.5 Advanced Orthopaedics Key News & Latest Developments
7.22 ALGEOS
7.22.1 ALGEOS Company Summary
7.22.2 ALGEOS Business Overview
7.22.3 ALGEOS Cognitive Decline Major Product Offerings
7.22.4 ALGEOS Cognitive Decline Revenue in Global Market (2018-2023)
7.22.5 ALGEOS Key News & Latest Developments
7.23 Hollister Incorporated
7.23.1 Hollister Incorporated Company Summary
7.23.2 Hollister Incorporated Business Overview
7.23.3 Hollister Incorporated Cognitive Decline Major Product Offerings
7.23.4 Hollister Incorporated Cognitive Decline Revenue in Global Market (2018-2023)
7.23.5 Hollister Incorporated Key News & Latest Developments
7.24 ConvaTec Group plc
7.24.1 ConvaTec Group plc Company Summary
7.24.2 ConvaTec Group plc Business Overview
7.24.3 ConvaTec Group plc Cognitive Decline Major Product Offerings
7.24.4 ConvaTec Group plc Cognitive Decline Revenue in Global Market (2018-2023)
7.24.5 ConvaTec Group plc Key News & Latest Developments
7.25 Coloplast A/S
7.25.1 Coloplast A/S Company Summary
7.25.2 Coloplast A/S Business Overview
7.25.3 Coloplast A/S Cognitive Decline Major Product Offerings
7.25.4 Coloplast A/S Cognitive Decline Revenue in Global Market (2018-2023)
7.25.5 Coloplast A/S Key News & Latest Developments
7.26 Medline Industries Inc.
7.26.1 Medline Industries Inc. Company Summary
7.26.2 Medline Industries Inc. Business Overview
7.26.3 Medline Industries Inc. Cognitive Decline Major Product Offerings
7.26.4 Medline Industries Inc. Cognitive Decline Revenue in Global Market (2018-2023)
7.26.5 Medline Industries Inc. Key News & Latest Developments
7.27 Invacare Corporation
7.27.1 Invacare Corporation Company Summary
7.27.2 Invacare Corporation Business Overview
7.27.3 Invacare Corporation Cognitive Decline Major Product Offerings
7.27.4 Invacare Corporation Cognitive Decline Revenue in Global Market (2018-2023)
7.27.5 Invacare Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMG23LY8428 )"認知機能低下のグローバル市場展望 2023年-2029年:リンエステラーゼ阻害剤、NMDA受容体拮抗薬" (英文:Cognitive Decline Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。